HtrA2/Omi influences the stability of LON protease 1 and prohibitin, proteins involved in mitochondrial homeostasis

Experimental Cell Research

Volumn 328, Issue 2, 2014, Pages 456-465

  Goo, Hui Gwan ^a   Rhim, Hyangshuk ^b   Kang, Seongman ^a  

^a Korea University   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

HtrA2; Mitochondria; Mitochondrial homeostasis; Mnd2; PHB; Protein quality control

Indexed keywords

ADENOSINE TRIPHOSPHATE; ENDOPEPTIDASE LA; LON PROTEASE 1; MITOCHONDRIAL PROTEIN; PROHIBITIN; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE OMI; UNCLASSIFIED DRUG; WT1 PROTEIN; X LINKED INHIBITOR OF APOPTOSIS; REPRESSOR PROTEIN; SERINE PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIVISION; COMPARATIVE STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE SILENCING; GENETIC TRANSFECTION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; LUMINESCENCE; MISSENSE MUTATION; MITOCHONDRIAL HOMEOSTASIS; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOTOR NEURON DEGENERATION 2; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STABILITY; QUALITY CONTROL; WILD TYPE; ANIMAL; CELL LINE; FIBROBLAST; HEK293 CELL LINE; METABOLISM; MITOCHONDRION; PHYSIOLOGY;

ANIMALS; CELL LINE; FIBROBLASTS; HEK293 CELLS; HOMEOSTASIS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; PROTEASE LA; REACTIVE OXYGEN SPECIES; REPRESSOR PROTEINS; SERINE ENDOPEPTIDASES;

EID: 84908237888     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.07.032     Document Type: Article

References (41)

1. Suzuki Y., Imai Y., Nakayama H., Takahashi K., Takio K., Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell 2001, 8:613-621.
2. Sekine K., Hao Y., Suzuki Y., Takahashi R., Tsuruo T., Naito M. HtrA2 cleaves Apollon and induces cell death by IAP-binding motif in Apollon-deficient cells. Biochem. Biophys. Res. Commun. 2005, 330:279-285.
3. Hartkamp J., Carpenter B., Roberts S.G. The Wilms' tumor suppressor protein WT1 is processed by the serine protease HtrA2/Omi. Mol. Cell 2010, 37:159-171.
4. Trencia A., Fiory F., Maitan M.A., Vito P., Barbagallo A.P., Perfetti A., Miele C., Ungaro P., Oriente F., Cilenti L., Zervos A.S., Formisano P., Beguinot F. Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15. J. Biol. Chem. 2004, 279:46566-46572.
5. Park H.M., Kim G.Y., Nam M.K., Seong G.H., Han C., Chung K.C., Kang S., Rhim H. The serine protease HtrA2/Omi cleaves Parkin and irreversibly inactivates its E3 ubiquitin ligase activity. Biochem. Biophys. Res. Commun. 2009, 387:537-542.
6. Park H.J., Kim S.S., Kang S., Rhim H. Intracellular Abeta and C99 aggregates induce mitochondria-dependent cell death in human neuroglioma H4 cells through recruitment of the 20S proteasome subunits. Brain Res. 2009, 1273:1-8.
7. Park H.J., Kim S.S., Seong Y.M., Kim K.H., Goo H.G., Yoon E.J., Min S., do S., Kang H. Rhim, Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. Implications for the physiological function of HtrA2 in the mitochondria. J. Biol. Chem. 2006, 281:34277-34287.
8. Jones J.M., Datta P., Srinivasula S.M., Ji W., Gupta S., Zhang Z., Davies E., Hajnoczky G., Saunders T.L., Van Keuren M.L., Fernandes-Alnemri T., Meisler M.H., Alnemri E.S. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 2003, 425:721-727.
9. Martins L.M., Morrison A., Klupsch K., Fedele V., Moisoi N., Teismann P., Abuin A., Grau E., Geppert M., Livi G.P., Creasy C.L., Martin A., Hargreaves I., Heales S.J., Okada H., Brandner S., Schulz J.B., Mak T., Downward J. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol. Cell. Biol. 2004, 24:9848-9862.
10. Ideguchi K., Shimizu S., Okumura M., Tsujimoto Y. Cyclophilin D-dependent mitochondrial permeability transition is not involved in neurodegeneration in mnd2 mutant mice. Biochem. Biophys. Res. Commun. 2010, 393:264-267.
11. Kang S., Louboutin J.P., Datta P., Landel C.P., Martinez D., Zervos A.S., Strayer D.S., Fernandes-Alnemri T., Alnemri E.S. Loss of HtrA2/Omi activity in non-neuronal tissues of adult mice causes premature aging. Cell Death Differ. 2013, 20:259-269.
12. Goo H.G., Jung M.K., Han S.S., Rhim H., Kang S. HtrA2/Omi deficiency causes damage and mutation of mitochondrial DNA. Biochim. Biophys. Acta 2013, 1833:1866-1875.
13. Plun-Favreau H., Klupsch K., Moisoi N., Gandhi S., Kjaer S., Frith D., Harvey K., Deas E., Harvey R.J., McDonald N., Wood N.W., Martins L.M., Downward J. The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat. Cell Biol. 2007, 9:1243-1252.
14. Plun-Favreau H., Gandhi S., Wood-Kaczmar A., Deas E., Yao Z., Wood N.W. What have PINK1 and HtrA2 genes told us about the role of mitochondria in Parkinson's disease?. Ann. N.Y. Acad. Sci. 2008, 1147:30-36.
15. Park H.J., Seong Y.M., Choi J.Y., Kang S., Rhim H. Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi. Neurosci. Lett. 2004, 357:63-67.
16. Pandya J.D., Nukala V.N., Sullivan P.G. Concentration dependent effect of calcium on brain mitochondrial bioenergetics and oxidative stress parameters. Front. Neuroenergetics 2013, 5:10.
17. Quincozes-Santos A., Bobermin L.D., Tramontina A.C., Wartchow K.M., Tagliari B., Souza D.O., Wyse A.T., Goncalves C.A. Oxidative stress mediated by NMDA, AMPA/KA channels in acute hippocampal slices: neuroprotective effect of resveratrol. Toxicol. In Vitro 2014, 28:544-551.
18. Xu H., Chen Y., Li Y., Xia F., Han B., Zhang H., Zhai H., Wu H., Lu Y. Mitochondrial apoptosis of lymphocyte is induced in type 2 diabetes. Chin. Med. J. 2014, 127:213-217.
19. Wang D.B., Kinoshita C., Kinoshita Y., Morrison R.S. p53 and mitochondrial function in neurons. Biochim. Biophys. Acta 2014, 1842(8):1186-1197.
20. Pradeep H., Sharma B., Rajanikant G.K. Drp1 in ischemic neuronal death: an unusual suspect. Curr. Med. Chem. 2014, 21(19):2183-2189.
21. Moisoi N., Fedele V., Edwards J., Martins L.M. Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson's disease triggered by mitochondrial stress. Neuropharmacology 2014, 77:350-357.
22. Matassa D.S., Amoroso M.R., Agliarulo I., Maddalena F., Sisinni L., Paladino S., Romano S., Romano M.F., Sagar V., Loreni F., Landriscina M., Esposito F. Translational control in the stress adaptive response of cancer cells: a novel role for the heat shock protein TRAP1. Cell Death Dis. 2013, 4:e851.
23. Chinnery P.F., Turnbull D.M. Mitochondrial DNA and disease. Lancet 1999, 354(Suppl 1):SI17-SI21.
24. Wallace D.C. Mitochondrial diseases in man and mouse. Science 1999, 283:1482-1488.
25. Lezi E., Swerdlow R.H. Mitochondria in neurodegeneration. Adv. Exp. Med. Biol. 2012, 942:269-286.
26. Cheng Z., Ristow M. Mitochondria and metabolic homeostasis. Antioxid. Redox Signal. 2013, 19:240-242.
27. Ngo J.K., Pomatto L.C., Bota D.A., Koop A.L., Davies K.J. Impairment of lon-induced protection against the accumulation of oxidized proteins in senescent wi-38 fibroblasts. J. Gerontol. Ser. A, Biol. Sci. Med. Sci. 2011, 66:1178-1185.
28. Bayot A., Gareil M., Rogowska-Wrzesinska A., Roepstorff P., Friguet B., Bulteau A.L. Identification of novel oxidized protein substrates and physiological partners of the mitochondrial ATP-dependent Lon-like protease Pim1. J. Biol. Chem. 2010, 285:11445-11457.
29. Komarova S.V., Ataullakhanov F.I., Globus R.K. Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts, American journal of physiology. Cell Physiol. 2000, 279:C1220-1229.
30. Kiesslich T., Benno Oberdanner C., Krammer B., Plaetzer K. Fast and reliable determination of intracellular ATP from cells cultured in 96-well microplates. J. Biochem. Biophys. Methods 2003, 57:247-251.
31. Martins L.M., Iaccarino I., Tenev T., Gschmeissner S., Totty N.F., Lemoine N.R., Savopoulos J., Gray C.W., Creasy C.L., Dingwall C., Downward J. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J. Biol. Chem. 2002, 277:439-444.
32. Gray C.W., Ward R.V., Karran E., Turconi S., Rowles A., Viglienghi D., Southan C., Barton A., Fantom K.G., West A., Savopoulos J., Hassan N.J., Clinkenbeard H., Hanning C., Amegadzie B., Davis J.B., Dingwall C., Livi G.P., Creasy C.L. Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur. J. Biochem. / FEBS 2000, 267:5699-5710.
33. Back J.W., Sanz M.A., De Jong L., De Koning L.J., Nijtmans L.G., De Koster C.G., Grivell L.A., Van Der Spek H., Muijsers A.O. A structure for the yeast prohibitin complex: structure prediction and evidence from chemical crosslinking and mass spectrometry. Protein Sci. 2002, 11:2471-2478.
34. Gigante A.D., Andreazza A.C., Lafer B., Yatham L.N., Beasley C.L., Young L.T. Decreased mRNA expression of uncoupling protein 2, a mitochondrial proton transporter, in post-mortem prefrontal cortex from patients with bipolar disorder and schizophrenia. Neurosci. Lett. 2011, 505:47-51.
35. Aird K.M., Allensworth J.L., Batinic-Haberle I., Lyerly H.K., Dewhirst M.W., Devi G.R. ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells. Breast Cancer Res. Treat. 2012, 132:109-119.
36. Plun-Favreau H., Burchell V.S., Holmstrom K.M., Yao Z., Deas E., Cain K., Fedele V., Moisoi N., Campanella M., Miguel Martins L., Wood N.W., Gourine A.V., Abramov A.Y. HtrA2 deficiency causes mitochondrial uncoupling through the F(1)F(0)-ATP synthase and consequent ATP depletion. Cell Death Dis. 2012, 3:e335.
37. Ferrer I., Perez E., Dalfo E., Barrachina M. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease. Neurosci. Lett. 2007, 415:205-209.
38. Bulteau A.L., Bayot A. Mitochondrial proteases and cancer. Biochim. Biophys. Acta 2011, 1807:595-601.
39. Artal-Sanz M., Tavernarakis N. Prohibitin and mitochondrial biology. Trends Endocrinol. Metab. 2009, 20:394-401.
40. Jin S.M., Youle R.J. The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria. Autophagy 2013, 9:1750-1757.
41. Dias V., Junn E., Mouradian M.M. The role of oxidative stress in Parkinson's disease. J. Parkinson's Dis. 2013, 3:461-491.